AniLocus Inc. | In Vivo CRO

  • No products in the cart.

Preclinical In Vivo Contract Research Services Contact Us!
AniLocus   →  Blog   →  Events   →  The 3rd Annual Psychedelic Therapeutics & Drug Development Conference

The 3rd Annual Psychedelic Therapeutics & Drug Development Conference

by
on 11/11/2022
In: Events
Psychedelics Therapeutics - AniLocus Preclinical-Nonclinical In Vivo Studies Design & Testing

Details

Join thousands of attendees from the biopharmaceutical industry, academia, clinic, and government sharing advances in psychedelic therapeutics.

Special Topics Discussed at the Conference:

  • Clinical Trial Design
  • Risk Evaluation & Mitigation Strategy (REMS)
  • Abuse Potential
  • Practical Use/Indications
  • DEA Licensure & Policy Considerations
  • Emerging advances in Preclinical Psychedelic Therapeutics Studies
  • Psychedelics Clinical Data

Learn about FDA regulatory guidance in psychedelic therapeutics, toxicology studies, dosing studies, animal models, targets for drug development, and psychedelic drug design.

**AniLocus anticipates joining this meeting to discuss preclinical-nonclinical solutions for psychedelics therapeutics! Contact us to learn more about our services in Psychedelics Preclinical-Nonclinical In Vivo Studies Testing.**

Book Now

http://psychedelics-conference.com/

When & Where

May 15, 2023 (12:00 am) – May 16, 2023 (12:00 am)

San Francisco, CA

Organizer

Organized by Arrowhead Conferences.

Organized by Arrowhead Publishers, LLC.